tiprankstipranks
MaaT Pharma (FR:MAAT)
PARIS:MAAT
France Market
Holding FR:MAAT?
Track your performance easily

MaaT Pharma (MAAT) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
0Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
MaaT Pharma’s (MAAT) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting MaaT Pharma is a Buy.
MaaT Pharma’s (MAAT) 20-Day exponential moving average is 7.93, while MaaT Pharma’s (MAAT) share price is €7.88, making it a Sell.
MaaT Pharma’s (MAAT) 50-Day exponential moving average is 7.75, while MaaT Pharma’s (MAAT) share price is €7.88, making it a Buy.

MaaT Pharma (MAAT) Pivot Points

Dec 23, 2024, 05:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.81
7.89
7.95
8.03
8.09
8.17
8.23
Fibonacci
7.89
7.95
7.98
8.03
8.09
8.12
8.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MaaT Pharma (MAAT) Moving Averages

Dec 23, 2024, 05:23 AM
Period
Simple
Exponential
MA5
8.01Sell
7.98Sell
MA10
8.02Sell
7.98Sell
MA20
7.93Sell
7.93Sell
MA50
7.68Buy
7.75Buy
MA100
7.47Buy
7.64Buy
MA200
7.87Buy
7.76Buy
MaaT Pharma’s (MAAT) 10-Day exponential moving average is 7.98, while MaaT Pharma’s (MAAT) share price is €7.88, making it a Sell.
MaaT Pharma’s (MAAT) 100-Day exponential moving average is 7.64, while MaaT Pharma’s (MAAT) share price is €7.88, making it a Buy.
MaaT Pharma’s (MAAT) stock price is €7.88 and MaaT Pharma’s (MAAT) 50-day simple moving average is 7.68, creating a Buy signal.
MaaT Pharma’s (MAAT) stock price is €7.88 and MaaT Pharma’s (MAAT) 100-day simple moving average is 7.47, creating a Buy signal.
MaaT Pharma’s (MAAT) stock price is €7.88 and MaaT Pharma’s (MAAT) 200-day simple moving average is 7.87, creating a Buy signal.

MaaT Pharma (MAAT) Technical Indicators

Dec 23, 2024, 05:23 AM
Name
Value
Implied Action
RSI (14)
49.88
Neutral
STOCH (9,6)
27.04
Neutral
STOCHRSI (14)
50.45
Neutral
MACD (12,26)
0.08
Buy
ADX (14)
15.47
Buy
Williams %R
-64.86
Buy
CCI (14)
-2.61
Neutral
ATR (14)
0.20
-
Ultimate Oscillator
30.12
Neutral
ROC
0.00
-
MaaT Pharma’s (MAAT) Relative Strength Index (RSI) is 49.88, creating a Neutral signal.
MaaT Pharma’s (MAAT) Trend Strength Indicator (ADX) is 15.47, creating a Buy signal.
MaaT Pharma’s (MAAT) Commodity Channel Index (CCI) is -2.61, creating a Neutral signal.

FAQ

Is MAAT a Buy, Hold, or Sell?
Based on MAAT’s technical indicators, MAAT is a Buy.
    What is MAAT’s RSI (14)?
    MAAT’s RSI (14) is 49.88, which suggests MAAT is a Neutral.
      What is MAAT’s MACD?
      MAAT’s MACD is 0.08, which suggests MAAT is a Buy.
        What is MAAT’s 5-day moving average?
        MAAT’s 5-day moving average is 8.01, which suggests MAAT is a Sell.
          What is MAAT’s 20-day moving average?
          MAAT 20-day moving average is 7.93, which suggests MAAT is a Sell.
            What is MAAT’s 50-day moving average?
            MAAT’s 50-day moving average is 7.68, which suggests MAAT is a Buy.
              What is MAAT’s 200-day moving average?
              MAAT’s 200-day moving average is 7.87, which suggests MAAT is a Buy.
                What is MAAT’s Williams % R (14)?
                MAAT’s Williams % R (14) is -64.86, which suggests MAAT is a Buy.
                  What is MAAT’s CCI (14)?
                  MAAT’s CCI (14) is -2.61, which suggests MAAT is a Neutral.
                    What is the share price of MaaT Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis